Pharmaceutical major Lupin Ltd., announced today that it has broken ground to set up a new state-of-the-art formulation manufacturing facility at the Special Economic Zone (SEZ), MIHAN, Nagpur. The Greenfield plant will take close to a year to being set up.
Lupin today operates 11 world class manufacturing facilities spread across India & Japan. Almost all of Lupin’s facilities have been inspected by leading regulators like the US FDA, UK MHRA, WHO, Australian TGA, and Japan’s MHLW.
Commenting on the development, Nilesh Gupta, Group President & Executive Director, Lupin Limited, said, “The strategic investment in the new formulation facility at MIHAN is not only in keeping with the consistent growth that Lupin has witnessed across key markets like the U.S. but it would also ensure that our manufacturing capacities are attuned to future demand. Nagpur as a location has strategic proximity to key metros as well as international aviation routes. We are happy to be here at MIHAN and to be able to contribute to the development of the local economy.”
